TNFRSF19 and myeloproliferative disorder: TNFRSF19 is overexpressed in glioblastoma correlating with tumor grade [67], in myeloproliferative neoplasms [68], melanoma [69], lung cancer [70], and nasopharyngeal carcinoma where it is required for cell proliferation [34].